on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at Emerging Growth Conference and Host Investor Webcast
Jaguar Health, Inc. announced its participation in the Emerging Growth Conference on March 27, 2025. CEO Lisa Conte will present virtually at the event. The company also plans an investor webcast on March 31, 2025, to discuss Q4 2024 financial outcomes and corporate updates. The event will highlight the progress in crofelemer development for rare diseases and cancer therapy-related diarrhea.
Jaguar intends to file its annual report for 2024 on March 31, 2025. The webcast will provide insights into key catalysts anticipated in Q2 2025, potentially enhancing company value. Registration links for both the conference and webcast are available online. Archived copies of the webcast will be accessible on Jaguar’s site post-event.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news